Lilly to Donate Insulin KwikPens To Support Lower-Income Communities

Starting this month, Eli Lilly and Company will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and …

Invokana® Gets New Indication in Canada to Reduce Risks with Diabetic Kidney Disease

Health Canada has approved Invokana® (canagliflozin) as an adjunct to diet, exercise, and standard-of-care therapy, to reduce the risk of end-stage …

US FDA Approves Only Triple-Combo Tablet with Jardiance® for Adults with T2D

The U.S. Food and Drug Administration has approved Trijardy™ XR to lower blood sugar in adults with Type 2 diabetes, along with diet and …

State of Illinois Passes Legislation to Cap Monthly Insulin Co-Pays

Governor J.B. Pritzker signed legislation that will cap insulin co-pays in the state of Illinois last week. The legislation, Senate Bill 667 (SB …

Diabetes Screening At the Barber Shop Maybe Beneficial for African Americans

It turns out that getting a hair cut maybe a good time for African Americans to also get a blood glucose screening, according to a new study. The …

AADE Rebrands as Association of Diabetes Care & Education Specialists (ADCES)

The American Association of Diabetes Educators announced that the organization has changed its name to reflect the association’s shift to a …

CDC Confirms First Case of Wuhan coronavirus In The U.S.

The Center for Disease Control (CDC) confirmed the first case of Wuhan coronavirus in the U.S. today. The patient, who recently returned home from a …

Tandem Launches the t:slim X2 Insulin Pump with Control-IQ Tech. in the U.S.

Tandem Diabetes Care, Inc. today announced the commercial launch of the t:slim X2™ insulin pump with Control-IQ™ technology, an …

Study Finds A New Computer Algorithm Predicts Gestational Diabetes

A new computer algorithm can predict in the early stages of pregnancy, or even before pregnancy has occurred, in which women are at a high risk of …

Behavior Change Company Raises $21M to Roll Out Digital Diabetes Treatment in Europe

Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding. The new capital will be used to further …